相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immunogenicity, safety and tolerability of intradermal influenza vaccines
Ivan F. N. Hung et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Hepatitis B vaccine nonresponders Possible mechanisms and solutions
Tara Vinyette Saco et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Chronic hepatitis B virus infection
Wai-Kay Seto et al.
LANCET (2018)
Comparison of Intradermal Route and Dose of Hepatitis B Vaccine Administration in Chronic Dialysis Patients: A Pilot Study
Rajesh Jhorawat et al.
SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION (2018)
A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix BA®, among vaccine na⟨ve and vaccine non-responder dialysis patients
E. Elhanan et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2018)
Immunogenicity, antibody persistence, and safety of the 60g hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial
Yongliang Feng et al.
EXPERT REVIEW OF VACCINES (2017)
The accelerated hepatitis B virus vaccination schedule among hemodialysis patients, does it work? A randomized controlled trial
Mahmoud Hamada Imam
JOURNAL OF NEPHROLOGY (2017)
Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial
Ivan Fan-Ngai Hung et al.
LANCET INFECTIOUS DISEASES (2016)
Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands as Influenza Virus Vaccine Adjuvants Induce Rapid, Sustained, and Broadly Protective Responses
Peter H. Goff et al.
JOURNAL OF VIROLOGY (2015)
Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study
Fabrizio Fabrizi et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2015)
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitus
Julia M. Janssen et al.
VACCINE (2015)
Toll-Like Receptor 7 Agonist Imiquimod in Combination with Influenza Vaccine Expedites and Augments Humoral Immune Responses against Influenza A(H1N1) pdm09 Virus Infection in BALB/c Mice
Anna J. X. Zhang et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Immunogenicity of Intradermal Trivalent Influenza Vaccine With Topical Imiquimod: A Double Blind Randomized Controlled Trial
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2014)
Hepatitis B virus infection
Christian Trepo et al.
LANCET (2014)
Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients
Theodoros Eleftheriadis et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain
Ivan F. N. Hung et al.
VACCINE (2012)
Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination
Ivan F. N. Hung et al.
VACCINE (2012)
Programming the magnitude and persistence of antibody responses with innate immunity
Sudhir Pai Kasturi et al.
NATURE (2011)
Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary Vaccination
Katherine A. Barraclough et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients
Hasan Micozkadioglu et al.
RENAL FAILURE (2007)
Hepatitis B virus infection in dialysis patients
PN Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)